On May 4, 2023, the U.S. Food and Drug Administration (FDA) is hosting a webinar for patients, industry, and other interested stakeholders to discuss and answer questions about the draft guidance: Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints
